Ajouter aux favoris   Ajouter cette page à mon bookmark --- SOCIAL BOOKMARKING --- Digg Furl del.icio.us Netscape

This BCC Research market opportunity study provides an in-depth analysis of the relevant technical and economic drivers of the medical membrane device market by technology type, forecast growth and trends in the various sectors over the next 5 years. Conclusions are illustrated with important statistical and analytical information on markets, applications, industry structure and dynamics, as well as technological developments. 
 

INTRODUCTION

STUDY GOAL AND OBJECTIVES

REASONS FOR DOING THIS STUDY

CONTRIBUTIONS OF THE STUDY AND FOR WHOM

SCOPE AND FORMAT

METHODOLOGY

INFORMATION SOURCES

ANALYSTS CREDENTIALS

RELATED BCC PUBLICATIONS

BCC ONLINE SERVICES

DISCLAIMER

SUMMARY

Summary Table:

SALES AND PROJECTIONS FOR MEDICAL MEMBRANE DEVICES, THROUGH 2012 ($ MILLIONS)

Summary Figure:

SALES AND PROJECTIONS FOR MEDICAL MEMBRANE DEVICES, 2000-2012 ($ MILLIONS)

OVERVIEW

OVERVIEW

Table 1 MEDICAL MEMBRANE DEVICES

INDUSTRY STRUCTURE

MEMBRANE AND DEVICE MANUFACTURERS

OEM MANUFACTURERS

OEM Membranes

Table 2 MANUFACTURERS OF OEM MEMBRANES AND PRODUCTS

OEM Devices

COMBINED MEMBRANE AND DEVICE MANUFACTURERS

HEALTHCARE PRODUCT OR MEDICAL TECHNOLOGY COMPANIES

DISTRIBUTION CHANNELS

UPSTREAM SUPPLIERS

PRODUCT DISTRIBUTION (MARKETING AND SALES)

Table 3 MEDICAL MEMBRANE DEVICE DISTRIBUTION CHANNELS

CUSTOMERS

Healthcare Customers

Downstream Manufacturing Customers

Distributors or Partnership-type Customers

Home Users

INDUSTRY PARTICIPANTS

Table 4 MEDICAL MEMBRANE DEVICE MANUFACTURERS AND PRODUCT SALES,

COMPANY PROFILES

3M

CUNO, INC.

ABBOTT LABORATORIES

ASAHI KASEI

AVITAR, INC.

BAXTER INTERNATIONAL

BECTON, DICKINSON & CO.

B.BRAUN MEDICAL INC.

CANTEL MEDICAL

CARDIOTECH INTERNATIONAL

DADE BEHRING

ENZO BIOCHEM

EPS, INC.

ESCO TECHNOLOGIES

FENWAL, INC.

FRESENIUS AG

GAMBRO AB

GENBIO

GENERAL ELECTRIC

W.L.GORE & ASSOCIATES

F. HOFFMAN-LA ROCHE

IMMUNETICS, INC.

INVERNESS MEDICAL INNOVATIONS, INC.

JOHNSON & JOHNSON

KANEKA CORP.

KURARAY CO, LTD.

MEDTRONIC

MILLIPORE CORP.

NOVOSCI

PALL CORP.

QUIDEL CORP.

RESPONSE BIOMEDICAL

SARTORIUS AG

SIEMENS MEDICAL SOLUTIONS

SORIN GROUP

SPECTRAL DIAGNOSTICS, INC.

TERUMO CORP.

THERMO FISHER SCIENTIFIC

TORAY INDUSTRIES, INC.

VARIAN, INC.

WHATMAN

TRENDS IN DEVICE MANUFACTURE

MARKET BARRIERS

MEDICAL DEVICE INDUSTRY REGULATION

Class I

Class II

Class III

Legal Liability

HEALTHCARE SYSTEM CONSIDERATIONS

Table 5 HEALTHCARE SPENDING AS A PERCENTAGE OF GROSS NATIONAL PRODUCT, 1960-2015 (%)

Figure 1 HEALTHCARE SPENDING AS A PERCENTAGE OF GROSS NATIONAL PRODUCT, 1960-2015 (%)

WHERE THE MONEY GOES

Table 6 NATIONAL HEALTH EXPENDITURES BY SERVICE, 2006 AND

Figure 2 NATIONAL HEALTH EXPENDITURES BY SERVICE, 2006 AND 2015 ($ BILLIONS)

WHY COSTS ARE RISING

ACCESS TO CARE

Table 7 HEALTHCARE COVERAGE IN THE U.S.,

Figure 3 HEALTHCARE COVERAGE IN THE U.S.,

MANAGED CARE

Capitation-type Reimbursement

Consolidation and Commercialization

HOW MANAGED CARE AFFECTS THE MEDICAL DEVICE MARKET

VERTICAL INTEGRATION OF PRODUCT AND CARE MARKETS

RECENT LEGISLATION

MEDICAL DEVICE USER FEE AND MODERNIZATION ACT OF

Table 8 DEVICE REVIEW USER FEES (FY 2007)

Table 9 FDA PERFORMANCE GOALS UNDER THE MEDICAL DEVICE USER FEE AND MODERNIZATION ACT OF

MEDICARE MODERNIZATION ACT OF

MEDICAL MEMBRANE DEVICE TECHNOLOGY

MEMBRANE MANUFACTURING

POLYMERS

Table 10 APPROPRIATE POLYMERS FOR MEDICAL MEMBRANES

Medical Use Criteria for Polymers

MANUFACTURING TECHNIQUES

Table 11 MEMBRANE MANUFACTURING METHODS

MEMBRANE STRUCTURES

Table 12 MEMBRANE MORPHOLOGIES AND PROPERTIES

MEMBRANE GEOMETRIES

Table 13 HOLLOW FIBER AND FLAT SHEET MEMBRANES AND DEVICES

TECHNICAL PARAMETERS OF MEDICAL MEMBRANE DEVICES

Table 14 TECHNICAL PARAMETERS OF MEDICAL MEMBRANE DEVICES

DEVICE MANUFACTURING

MARKET ANALYSIS

DEVICE CONCEPT

DEVICE DESIGN

DEVICE PROTOTYPE

PRODUCT SPECIFICATION

TRANSFER TO PRODUCTION

PRODUCTION RATIONALIZATION

MARKET INTRODUCTION

PRICING

Table 15 AVERAGE PRICES FOR MEDICAL MEMBRANE DEVICES

COMPETITIVE TECHNOLOGIES

Table 16 MEDICAL MEMBRANE DEVICES AND COMPETING TECHNOLOGIES

PATENT SURVEY

INTRODUCTION

BY APPLICATION

Table 17 PATENTS BY APPLICATION

Figure 4 PATENTS BY APPLICATION (%)

BY COMPANY

Table 18 PATENTS BY COMPANY

Figure 5 PATENTS BY COMPANY (%)

HEMODIALYZERS

MARKET SIZE AND GROWTH

Table 19 SALES AND PROJECTIONS FOR HEMODIALYZERS, THROUGH 2012 ($ MILLIONS)

Figure 6 SALES AND PROJECTIONS FOR HEMODIALYZERS, 2000-2012 ($ MILLIONS)

HISTORY

OVERVIEW

DIALYZERS

DIALYZER SPECIFICATIONS

Table 20 U.S. DIALYZER MARKET BY MEMBRANE TYPE

HEMODIALYSIS MODES

MEASURING DIALYZER PERFORMANCE

DIALYZER REUSE

COMPETITIVE TECHNOLOGIES

COMPANIES ACTIVE IN THE DIALYZER INDUSTRY

Table 21 MANUFACTURERS OF DIALYZERS AND RELATED PRODUCTS

HEMODIALYZERS: MARKET SHARE

Table 22 HEMODIALYZERS MARKET SHARE,

Figure 7 HEMODIALYZERS MARKET SHARE,

BLOOD OXYGENATORS

MARKET SIZE AND GROWTH

Table 23 SALES AND PROJECTIONS FOR BLOOD OXYGENATORS, THROUGH 2012 ($ MILLIONS)

Figure 8 SALES AND PROJECTIONS FOR BLOOD OXYGENATORS, 2000-2012 ($ MILLIONS)

HISTORY

OVERVIEW

BLOOD OXYGENATORS

OXYGENATOR SPECIFICATIONS

COMPETITIVE TECHNOLOGIES

COMPANIES ACTIVE IN THE BLOOD OXYGENATOR MARKET

Table 24 MEMBRANE OXYGENATOR MANUFACTURERS AND PRODUCTS

BLOOD OXYGENATORS: MARKET SHARE

Table 25 BLOOD OXYGENATORS MARKET SHARE,

Figure 9 BLOOD OXYGENATORS MARKET SHARE, 2007 (%)

IV FILTERS

MARKET SIZE AND GROWTH

Table 26 SALES AND PROJECTIONS FOR IV FILTERS, THROUGH 2012 ($ MILLIONS)

Figure 10 SALES AND PROJECTIONS FOR IV FILTERS, 2000-2012 ($ MILLIONS)

HISTORY

OVERVIEW

ENDOTOXIN REMOVAL

NUTRIENT ADMIXTURE FILTRATION

INLINE BLOOD COMPONENT FILTRATION

EMULSION DRUGS

Table 27 DRUGS FOR WHICH FILTRATION IS RECOMMENDED DURING ADMINISTRATION

INFANT IV THERAPY

COMPANIES ACTIVE IN THE IV FILTER MARKET

Table 28 MANUFACTURERS OF IV FILTERS AND PRODUCTS

IV FILTERS: MARKET SHARE

DIAGNOSTIC DEVICES

MARKET SIZE AND GROWTH

Table 29 SALES AND PROJECTIONS FOR DIAGNOSTIC DEVICES, THROUGH 2012 ($ MILLIONS)

Figure 11 SALES AND PROJECTIONS FOR DIAGNOSTIC DEVICES, 2000-2012 ($ MILLIONS)

HISTORY

OVERVIEW

CLINICAL DIAGNOSTICS

POINT-OF-CARE TESTING (POC)

Table 30 CONDITIONS DETECTED BY IN VITRO DIAGNOSTICS

HOME TESTING

ASSAY TYPES

Challenges in Assay Design

TECHNOLOGY

COMPETITIVE TECHNOLOGIES

Table 31 ALTERNATIVE METHODS OF IN VITRO TESTING

Table 32 MEMBRANE APPLICATIONS IN MOLECULAR DIAGNOSTICS

TRENDS AND TECHNICAL DEVELOPMENTS

AUTOMATION

NONINVASIVE SAMPLING

THE DISAPPEARING SAMPLE

COMPANIES ACTIVE IN THE DIAGNOSTIC DEVICE MARKET

Table 33 MANUFACTURERS OF DIAGNOSTIC DEVICES AND PRODUCTS

DIAGNOSTIC DEVICES: MARKET SHARE

Table 34 DIAGNOSTIC DEVICES MARKET SHARE,

Figure 12 DIAGNOSTIC DEVICES MARKET SHARE, 2007 (%)

BLOOD MICROFILTERS

MARKET SIZE AND GROWTH

Table 35 SALES AND PROJECTIONS FOR BLOOD MICROFILTERS, THROUGH 2012 ($ MILLIONS)

Figure 13 SALES AND PROJECTIONS FOR BLOOD MICROFILTERS, 2000-2012 ($ MILLIONS)

HISTORY

OVERVIEW

Table 36 THERAPEUTIC APHERESIS OUTCOMES AND GUIDELINES

TECHNOLOGY

Table 37 COMPARISONS OF BLOOD FRACTIONATION TECHNOLOGY

TRENDS AND TECHNICAL DEVELOPMENTS

Table 38 THERAPEUTIC APHERESIS DEVELOPMENTS

Table 39 POTENTIAL APPLICATIONS FOR THERAPEUTIC APHERESIS

COMPANIES ACTIVE IN THE BLOOD MICROFILTER MARKET

Table 40 MANUFACTURERS OF BLOOD MICROFILTERS AND PRODUCTS

MARKET SHARE: BLOOD MICROFILTERS

Table 41 BLOOD MICROFILTERS: 2007 MARKET SHARE

THE OVERSEAS MEDICAL MEMBRANE DEVICE MARKET

THE OVERSEAS MEDICAL MEMBRANE DEVICE MARKET

APPENDIX I

Table 42 PATENT SURVEY

LIST OF TABLES

Summary Table:

SALES AND PROJECTIONS FOR MEDICAL MEMBRANE DEVICES, THROUGH 2012 ($ MILLIONS)

Table 1 MEDICAL MEMBRANE DEVICES

Table 2 MANUFACTURERS OF OEM MEMBRANES AND PRODUCTS

Table 3 MEDICAL MEMBRANE DEVICE DISTRIBUTION CHANNELS

Table 4 MEDICAL MEMBRANE DEVICE MANUFACTURERS AND PRODUCT SALES,

Table 5 HEALTHCARE SPENDING AS A PERCENTAGE OF GROSS NATIONAL PRODUCT, 1960-2015 (%)

Table 6 NATIONAL HEALTH EXPENDITURES BY SERVICE, 2006 AND

Table 7 HEALTHCARE COVERAGE IN THE U.S.,

Table 8 DEVICE REVIEW USER FEES (FY 2007)

Table 9 FDA PERFORMANCE GOALS UNDER THE MEDICAL DEVICE USER FEE AND MODERNIZATION ACT OF

Table 10 APPROPRIATE POLYMERS FOR MEDICAL MEMBRANES

Table 11 MEMBRANE MANUFACTURING METHODS

Table 12 MEMBRANE MORPHOLOGIES AND PROPERTIES

Table 13 HOLLOW FIBER AND FLAT SHEET MEMBRANES AND DEVICES

Table 14 TECHNICAL PARAMETERS OF MEDICAL MEMBRANE DEVICES

Table 15 AVERAGE PRICES FOR MEDICAL MEMBRANE DEVICES

Table 16 MEDICAL MEMBRANE DEVICES AND COMPETING TECHNOLOGIES

Table 17 PATENTS BY APPLICATION

Table 18 PATENTS BY COMPANY

Table 19 SALES AND PROJECTIONS FOR HEMODIALYZERS, THROUGH 2012 ($ MILLIONS)

Table 20 U.S. DIALYZER MARKET BY MEMBRANE TYPE

Table 21 MANUFACTURERS OF DIALYZERS AND RELATED PRODUCTS

Table 22 HEMODIALYZERS MARKET SHARE,

Table 23 SALES AND PROJECTIONS FOR BLOOD OXYGENATORS, THROUGH 2012 ($ MILLIONS)

Table 24 MEMBRANE OXYGENATOR MANUFACTURERS AND PRODUCTS

Table 25 BLOOD OXYGENATORS MARKET SHARE,

Table 26 SALES AND PROJECTIONS FOR IV FILTERS, THROUGH 2012 ($ MILLIONS)

Table 27 DRUGS FOR WHICH FILTRATION IS RECOMMENDED DURING ADMINISTRATION

Table 28 MANUFACTURERS OF IV FILTERS AND PRODUCTS

Table 29 SALES AND PROJECTIONS FOR DIAGNOSTIC DEVICES, THROUGH 2012 ($ MILLIONS)

Table 30 CONDITIONS DETECTED BY IN VITRO DIAGNOSTICS

Table 31 ALTERNATIVE METHODS OF IN VITRO TESTING

Table 32 MEMBRANE APPLICATIONS IN MOLECULAR DIAGNOSTICS

Table 33 MANUFACTURERS OF DIAGNOSTIC DEVICES AND PRODUCTS

Table 34 DIAGNOSTIC DEVICES MARKET SHARE,

Table 35 SALES AND PROJECTIONS FOR BLOOD MICROFILTERS, THROUGH 2012 ($ MILLIONS)

Table 36 THERAPEUTIC APHERESIS OUTCOMES AND GUIDELINES

Table 37 COMPARISONS OF BLOOD FRACTIONATION TECHNOLOGY

Table 38 THERAPEUTIC APHERESIS DEVELOPMENTS

Table 39 POTENTIAL APPLICATIONS FOR THERAPEUTIC APHERESIS

Table 40 MANUFACTURERS OF BLOOD MICROFILTERS AND PRODUCTS

Table 41 BLOOD MICROFILTERS: 2007 MARKET SHARE

Table 42 PATENT SURVEY

LIST OF FIGURES

Summary Figure:

SALES AND PROJECTIONS FOR MEDICAL MEMBRANE DEVICES, 2000-2012 ($ MILLIONS)

XVII

Figure 1 HEALTHCARE SPENDING AS A PERCENTAGE OF GROSS NATIONAL PRODUCT, 1960-2015 (%)

Figure 2 NATIONAL HEALTH EXPENDITURES BY SERVICE, 2006 AND 2015 ($ BILLIONS)

Figure 3 HEALTHCARE COVERAGE IN THE U.S.,

Figure 4 PATENTS BY APPLICATION (%)

Figure 5 PATENTS BY COMPANY (%)

Figure 6 SALES AND PROJECTIONS FOR HEMODIALYZERS, 2000-2012 ($ MILLIONS)

Figure 7 HEMODIALYZERS MARKET SHARE,

Figure 8 SALES AND PROJECTIONS FOR BLOOD OXYGENATORS, 2000-2012 ($ MILLIONS)

Figure 9 BLOOD OXYGENATORS MARKET SHARE, 2007 (%)

Figure 10 SALES AND PROJECTIONS FOR IV FILTERS, 2000-2012 ($ MILLIONS)

Figure 11 SALES AND PROJECTIONS FOR DIAGNOSTIC DEVICES, 2000-2012 ($ MILLIONS)

Figure 12 DIAGNOSTIC DEVICES MARKET SHARE, 2007 (%)

Figure 13 SALES AND PROJECTIONS FOR BLOOD MICROFILTERS, 2000-2012 ($ MILLIONS)